Label-free interaction analysis is of increasing importance for scientists in the academic, pharmaceutical, biotechnology and diagnostic markets. Setting the performance benchmark, Biacore??systems generate unique data on the interactions between proteins and other molecules, including small molecule drug candidates. During research, development and manufacture, these data give insights into protein functionality, elucidate disease mechanisms and play a key role in the critical decisions needed for efficient development and production of therapeutics.
Biacore systems are used in areas such as pharmaceutical drug discovery, antibody characterization, proteomics, immunogenicity, biotherapeutic development and manufacture, and many life science research applications. A range of systems meet specific application needs. Customers include leading research centers, all of the leading global pharmaceutical companies, and many biotechnology companies.
In the food analysis market, a system and ready-to-use kits provide key manufacturers with the ability to determine quality and safety in areas such as quantification of vitamin content and screening for veterinary drug residues.
Biacore AB is a GE Healthcare company. Further information: www.biacore.com